VTGN

VISTAGEN THERAPEUTICS INC

VTGN·92840H400·US·Common Stock·Healthcare - Biotechnology-13D/G

VTGN (VISTAGEN THERAPEUTICS INC) is held by 33 institutional investors as of Q1 2026. Largest holders: VANGUARD CAPITAL MANAGEMENT LLC ($900,442), TWO SIGMA INVESTMENTS, LP ($268,387), GEODE CAPITAL MANAGEMENT, LLC ($259,170). Net institutional sentiment: Mixed.

33
Holders
Avg rating(6 Elite)
$2.9M
Total Value
51% (42)
Fund Consensus
18 buying - 17 selling
VTGNSmart Money Verdict
View all
Held by 33 funds
6 elite
Who's Trading
ActivistCYChen Yu10.0%May 15, 2026
ActivistSTStemPoint Capital LP1.5%Feb 17, 2026
ActivistCOCommodore Capital LP9.9%Feb 17, 2026
ActivistJANUS HENDERSON GROUP PLCJANUS HENDERSON GROUP PLC0.0%Feb 17, 2026
ActivistOAORBIMED ADVISORS LLC3.6%Feb 17, 2026
ActivistGPGreat Point Partners, LLC5.0%Feb 17, 2026
ActivistNANantahala Capital Management, LLC4.7%Feb 13, 2026
ActivistThe Vanguard GroupThe Vanguard Group4.6%Jan 30, 2026
13F: Insider & Congress:
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
New
1.6M$900,4420.0%-57.38%
38
Increased
469,619(+140.1%)$268,3870.0%-86.10%
38
Increased
453,391(+28.5%)$259,1700.0%-97.44%
20
Increased
448,507(+6.1%)$256,3220.0%-90.34%
17
Increased
430,404(+118.4%)$245,9760.0%-66.64%
37
Increased
291,300(+81.2%)$166,4780.0%-88.20%
35
Decreased
272,811(-48.3%)$155,9120.0%-87.25%
0
New
217,700$124,5240.0%-57.38%
34
New
152,849$87,3530.0%-57.38%
30
Decreased
142,607(-57.4%)$81,5000.0%-80.35%
0
Unchanged
121,114$69,2170.0%-93.60%
0
Increased
106,172(+39.4%)$60,6770.0%-60.62%
28
New
89,649$51,2790.0%-57.38%
31
Increased
78,736(+51.4%)$45,0370.0%-81.45%
19
Unchanged
72,655$41,5220.0%-97.64%
0
New
53,100$30,3470.0%-57.38%
30
Increased
26,589(+22.3%)$15,1940.0%-85.85%
22
Decreased
26,000(-0.1%)$14,8590.0%-89.68%
0
Unchanged
20,628$11,7890.0%-91.53%
0
Decreased
19,875(-81.3%)$11,3590.0%-81.40%
0

Showing 1-20 of 42

1 / 3

Other Healthcare stocks held by institutions

Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used